Terbequinil (SR-25776) is an experimental chemical compound that has been investigated for modulation of the GABA<sub>A</sub> receptor. Public drug and chemistry databases describe it as a quinoline derivative with carboxamide and ether functional groups.
The compound has been the subject of preclinical and early clinical investigations but is not approved for medical use and has no active marketed indications.